Janet Lee Overview
- Investor Type
-
Angel
- Investments
-
2
- Exits
-
2
Janet Lee General Information
Description
Ms. Janet Lee served as Managing Director, Public Equity at Invus Group. She manages the healthcare portfolio and is the director of research for the Public Equity group. Prior to joining Invus in 2009, Janet worked on healthcare public equity investments at Origin Capital Management, a healthcare-focused hedge fund. Previously, Janet was a consultant at McKinsey & Company, where she worked with financial services clients in Asia and the U.S. on growth strategy, M&A, and risk management. Janet graduated from Yale University.
Contact Information
Primary Investor Type
Angel (individual)
Janet Lee Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| DTx Pharma | 06-Jan-2020 | Early Stage VC | 0000 | Drug Delivery | Generating Revenue | 00000 000 |
| ConciergeStat | 01-Apr-2014 | 00000 00000 | Business/Productivity Software | Generating Revenue | 00000 000 |
Janet Lee Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| DTx Pharma | 17-Jul-2023 | Merger/Acquisition | 000 |
| ConciergeStat | 04-Aug-2018 | 000000000000000000 |
Janet Lee Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Janet Lee Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Janet Lee | Angel Investor | 0 |
Janet Lee Co-Investors (12)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Charlesson | 1 | 0 | 0 |
|
|
| Eli Lilly | 0 | 0 | 0 |
|
|
| Eric Schiffer | 0 | 0 | 0 |
|
|
| ExSight Ventures | 0 | 0 | 0 |
|
|
| Grant Cleve | 0 | 0 | 0 |
|
|